title: Comments on 'A dose-finding approach based on shrunken predictive probability for combinations of two agents in phase I trials' by Akihiro Hirakawa, Chikuma Hamada, and Shigeyuki Matsui.
authors.affiliation: Division of Translational Research & Applied Statistics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA 22908, U.S.A.
authors.forename: Nolan A
authors.initials: NA
authors.lastname: Wages
authors.forename: Mark R
authors.initials: MR
authors.lastname: Conaway
authors.forename: John
authors.initials: J
authors.lastname: O'Quigley
mesh_terms: D000465:Algorithms; D001499:Bayes Theorem; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D006801:Humans; D020714:Maximum Tolerated Dose; D015233:Models, Statistical